Drug Shortage Report for AVAMYS
| Report ID | 178681 |
| Drug Identification Number | 02298589 |
| Brand name | AVAMYS |
| Common or Proper name | fluticasone furoate nasal spray |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUTICASONE FUROATE |
| Strength(s) | 27.5MCG |
| Dosage form(s) | SPRAY, METERED DOSE |
| Route of administration | NASAL NASAL |
| Packaging size | 1x120 |
| ATC code | R01AD |
| ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-12-12 |
| Estimated end date | 2023-01-06 |
| Actual end date | 2023-01-03 |
| Shortage status | Resolved |
| Updated date | 2023-01-04 |
| Company comments | Managing supply due to high demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-01-04 | French | Compare |
| v3 | 2023-01-04 | English | Compare |
| v2 | 2022-12-16 | French | Compare |
| v1 | 2022-12-16 | English | Compare |
Showing 1 to 4 of 4